Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Efficacy and Safety of Privigen in Children and Adolescents With Primary Immunodeficiency
Pediatric Asthma, Allergy & Immunology, 08/03/09
Church JA et al. – The proportion of infusions with temporally associated AEs for the entire pediatric population was 0.18. One patient experienced serious AEs considered related to study drug and was withdrawn. Privigen was effective in sustaining a low incidence of infections, including aSBIs, and showed a good tolerability profile, with adverse events typical of disease and treatment.
Related Articles
Determinants of Vaccine Immunity in the Cohort of Human Immunodeficiency Virus-Infected Children Living in Switzerland
The Pediatric Infectious Disease Journal, 10/14/09
Relevance Score: 87%
Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus
Clinical and Experimental Dermatology, 10/05/09
Relevance Score: 87%
Oral Fluid Tests for Screening of Human Immunodeficiency Virus-Exposed Infants
The Pediatric Infectious Disease Journal, 11/12/09
Relevance Score: 85%
A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains
Journal of Virology, 10/12/09
Relevance Score: 85%
Myopericytoma in Patients With AIDS: A New Class of Epstein-Barr Virus-associated Tumor
American Journal of Surgical Pathology, 10/27/09
Relevance Score: 84%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
Journal of Allergy and Clinical Immunology, 11/25/09
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09
High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations
Journal of Allergy and Clinical Immunology, 11/25/09
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Smoking Cessation Among Women with and at Risk for HIV: Are They Quitting
Journal of General Internal Medicine, 11/25/09
Effect of Calcium-Modulating Cyclophilin Ligand on Human Immunodeficiency Virus Type 1 Particle Release and Cell Surface Expression of Tetherin
Journal of Virology, 11/25/09
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial
The Lancet - Early Online Publication, 11/25/09
Today in Peds Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09
Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans
Journal of Allergy and Clinical Immunology, 11/25/09
Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants: A Randomized Double-Blind Placebo-Controlled Study
The Pediatric Infectious Disease Journal, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


